Bioheal Therapeutics

Bioheal Therapeutics is a San Diego-based regenerative medicine company focused on addressing significant unmet needs in wound care. Its core technology is a patented, porcine amnion-hyaluronic acid hydrogel designed to be conformable, moisture-retentive, and non-adherent, aiming to simplify clinical workflows. The company is currently in the pre-commercial stage, seeking FDA clearance for its lead product, Protevion™ Hydrogel, which targets a large and growing market for advanced wound management. As a private, early-stage company, its near-term success hinges on regulatory approval and subsequent market adoption.

Proprietary hydrogel formulation combining processed porcine amnion (for regenerative factors) with hyaluronic acid (for moisture retention and structure), designed to create a flowable, conformable, and bioactive wound dressing.

Bioheal competes in the advanced wound dressing market against large medtech firms (e.g., 3M, Smith & Nephew, Mölnlycke) offering hydrogels and foams, as well as other regenerative medicine companies selling amniotic membrane products (often in sheet form). Its differentiation hinges on the combination of biological activity and superior physical form-factor.